GlassScriptPhysician profile
Arnold Rugama
NPI 1487656021
$1,253.33
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Sleep Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $330 · 2021: $381 · 2022: $273.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $427.91 | 2019-2022 | |
| Harmony Biosciences LLC | $215.10 | 2020-2022 | |
| Glaxosmithkline, LLC. | $214.99 | 2020-2021 | |
| Fisher & Paykel Healthcare INC | $119.94 | 2019-2022 | |
| Resmed Corp | $84.48 | 2019-2020 | |
| Pfizer INC. | $82.12 | 2019 | |
| Itamar Medical INC | $59.52 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $49.27 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Rugama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.